Genetic biomarkers in epilepsy. - Wikidata - wikimedia - TriplyDB

Genetic biomarkers in epilepsy.

Genetic biomarkers in epilepsy.

http://www.wikidata.org/entity/Q38190879

about

Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature.Individualizing Treatment Approaches for Epileptic Patients with Glucose Transporter Type1 (GLUT-1) Deficiency.

P2860

Q38414396-0892CD76-2F8F-4120-9737-1E66008BB964 Q47882020-A0831335-8196-4580-9775-CF1B9649267F

P2860

Genetic biomarkers in epilepsy.

http://www.wikidata.org/entity/Q38190879

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Genetic biomarkers in epilepsy.

@en

type

label

Genetic biomarkers in epilepsy.

@en

prefLabel

Genetic biomarkers in epilepsy.

@en

P1433

Q38190879-A0DC4FB9-A9B1-42F7-B4AB-F90D41CAEE0A

P1476

Q38190879-BF52B174-5AE6-483E-BF7A-113B9F1A0DE3

P2093

Q38190879-55B689CC-6E98-403C-B93F-7352E615EE07

Q38190879-78E39F39-9009-4745-AF07-46560C95AFAC

Q38190879-E5D7AE32-8DE5-49E1-BCA7-1260D22890F9

P2860

Q38190879-063353BA-8024-4578-856B-390C0013C994

Q38190879-068133BD-038D-4C94-B746-A2E73277DBAE

Q38190879-06E1F113-580B-45B8-95BF-55C7D20DCA99

Q38190879-070B1300-98AF-4C83-AA97-0BBD0BA59110

Q38190879-07BA5A25-6BD2-4AC5-B434-343CC62298C1

Q38190879-0C1B5D49-A3D0-4F36-8A35-20EBCA916482

Q38190879-0D2C5D4F-6A3F-4BF9-A91A-03EE1A93863E

Q38190879-12A726DF-B698-49E6-AD68-9DAB88C0003F

Q38190879-15316DA5-48BC-4425-A889-AEAA6018F937

Q38190879-15D771C1-230B-496E-A05F-B17496C76543

P2888

Q38190879-4D3226A9-6852-4F2C-A2C9-1FA14E11CF95

P304

Q38190879-3DE1B2ED-949A-40B1-A2A5-F6A7451B21AD

P31

Q38190879-4FDE92DB-54F9-43FE-9778-22CAAC5BD56D

P356

Q38190879-F221BADF-45FD-401F-B2E9-9030105C8708

P433

Q38190879-96B2CE52-D97D-42B8-8B7D-80C06AC1A3CB

P478

Q38190879-60B1F60A-F7F3-4C74-9678-8A5047B1C3E4

P50

Q38190879-AD2CAE91-9AC6-4DD4-89BE-DAF0A906101E

P577

Q38190879-214AD81C-0270-42FF-A2FD-9FD542B5EEFA

P698

Q38190879-F99BFC0F-B688-4404-BC04-61F0BE159DFD

P921

Q38190879-3545D710-CDEF-4F23-854D-CD0A836B7FC3

P932

Q38190879-E8A1CB4D-7A4B-44E7-BEAA-08F361E3B7DA

P356

S13311-014-0262-5

P1433

Neurotherapeutics

P1476

Genetic biomarkers in epilepsy.

@en

P2093

Holger Lerche

http://www.w3.org/2001/XMLSchema#string

Matthias Schwab

http://www.w3.org/2001/XMLSchema#string

Yvonne G Weber

http://www.w3.org/2001/XMLSchema#string

P2860

Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia

GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier

A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns

A potassium channel mutation in neonatal human epilepsy

De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.

Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1.

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

The multidrug transporter P-glycoprotein in pharmacoresistance to antiepileptic drugs

Ion channels in genetic and acquired forms of epilepsy.

P2888

s13311-014-0262-5

P304

324-333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13311-014-0262-5

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24566939

http://www.w3.org/2001/XMLSchema#string

P921

P932

3996127

http://www.w3.org/2001/XMLSchema#string